Total Funding
55
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
BONAC specializes in research and development of nucleic acid medicines.
Hirotake Hayashi: President and CEO- Yoshihiko Matsuo: Auditor
About the Company
Bonac specializes in nucleic acid chemistry, aiming to advance healthcare through the development of nucleic acid-based pharmaceuticals and diagnostic drugs. The company is committed to delivering medical solutions that contribute to the future of medicine. It fosters a collaborative environment where all team members are considered vital assets,
driving innovation and corporate value through shared dedication and daily efforts.
